The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Have we found a level to reverse the trend, where buyers are happy with the risk.
I think we will need some good news to actually get some momentum.
A 50% to 100% rise would return us to our previous undervalued level - Great profit for new buyers /traders.
It looks like more buys than sells, looking at the actual trade prices.
BB
TSG will not be an option at this time due to cash availability & SP.
TSG will be an option when we are profit making at a lot higher SP.
Hopefully we will get that option or at least first refusal in the future.
BB
Unless it's a buyer on the sell side with DMA.
It could be the final chunk from a big seller.
Let's see which way it goes, hopefully news on Friday/Monday relating to this weeks meetings.
BB
From RNS 03 Apr 23. 'The issue of 10,046,556 TG ordinary shares of £0.025 each to BAT covering a sum of AUD$9,750,000 (c.£5,284,500) at an issue price of £0.526 per ordinary share in two equal tranches as followws:
o 5,023,278 TG ordinary shares of £0.025 each issued at Completion (the "Tranche 1 Consideration Shares"); and
o 5,023,278 TG ordinary shares of £0.025 each to be issued on the eight month anniversary of Completion (the "Tranche 2 Consideration Shares").'
BAT will get the 2nd tranch on 1 Dec 23. Priced at 52.6p per ordinary share. They will have taken a real hit on the initial pricing of the aquisition.
Could they be the block seller or is there a lock-in period?
A couple of decent buys have come in, but not enough to change the price, yet!
BB
The market doesn't appear to like the way TGR is limping on, but it doesn't always get it right.
I wouldn't have been happy with a 10% equity raise prior to suspension, giving about £3.3m in cash minus costs. To do the same raise now only gets you £1.9m in cash minus costs. Those costs could be lower than the discount given on the graphite price for the cash up front option. Lets hope he's having some good discussions this week with prospective investors. The 12th June TGR closed at 41.5p. We need to hit that inflection point & soon.
BB
It's oversold, however, I imagine most buyers are waiting on the side lines to avoid risk, even though this will reduce their gains. We were oversold at 25p, so I guess they were right to stay out, we now need a 25% rise to get back to that level.
BB
Shashir can say 'No dilution' but cannot guarantee it. It's not always a bad thing, progress has been slower than planned and more capex/opex has ocurred. CLN's are ok as long as you can pay them back, or they issue shares to pay them off at a reasonable SP. Many companies has disappeared via a death spiral through the use of CLN's.
Im invested here and want to see this become a successful producer.
BB
From RNS 'The meetings will take place at a central location in the City of London during the week commencing 11 September 2023.'
Timings & duration depends on how many interested parties there are that would like a 1-2-1 meeting. May be news later this week. I'm expecting some dilution to come from this event, but cash in the bank and turning profitable, will cause this to re-rate (+100% minimum).
BB
PGM's normally reverse around $800, currently $890ish. However with inflation affecting everything, I would be surprised to see PGM's go that low. Care & maintenance will kick in earlier, this will hit the supply side and the price will rise. Unless a deep recession kicks in!
BB
Gaisan: Are you saying they are selling the product cheaply to Tirupati Speciality Graphite. If so this should be raised with the FCA . As the Directors have a Duty of Care to get the best possible returns for it's shareholders. Unluss it has MOU's in place to supply TGR, but we should know about these!
BB